Estradiol — Drug Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

7 Recruiting

3 Completed trials

7 Sponsors

5 Countries

Phase III

Phase II

Phase IV

Phase III: 3 Phase II: 3 Phase IV: 6

Indications tested

Turner's syndrome 2 Diabetes mellitus 1 Menopause 1

Sponsors using this IMP

Region Midtjylland 5 Amsterdam UMC Stichting 2 Amsterdam UMC 1 Central Finland Hospital District Central Finland Hospital Nova 1 Karolinska University Hospital 1 Rigshospitalet 1 Universitetssykehuset Nord-Norge HF 1

All trials

12 total

Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle… Not authorised

2023-504616-15-00 Phase III 1 country Region Midtjylland
Safety of oral micronized progesterone versus norethisterone acetate in continuous combination with oral estrogen as menopausal hormone ther… Pending

2024-520435-33-00 Phase III 1 country Karolinska University Hospital
The effect of transdermal 17-β-estradiol/progesterone supplementation on glucose regulation in peri- and postmenopausal women with type 1 an… Recruiting

2025-523214-83-00 Phase IV 1 country Amsterdam UMC Stichting
Sleeping through Menopause Recruiting

2024-512071-12-00 Phase IV 1 country Amsterdam UMC Stichting
Transdermal estradiol and exercise in mitigating adverse effects of androgen deprivation therapy for prostate cancer radiation therapy (ESTR… Recruiting

2023-504704-28-00 Phase II 1 country Central Finland Hospital District Central Finland Hospital Nova
Improving diagnostics in cervical dysplasia Recruiting

2024-517151-12-00 Phase IV 1 country Region Midtjylland
Rectally administered micronized progesterone for luteal phase support in hormone replacement therapy frozen embryo transfer (HRT-FET) cycle… Recruiting

2023-504616-15-02 Phase III 1 country Region Midtjylland
Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome Recruiting

2024-518001-18-00 Phase IV 1 country Region Midtjylland
Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women with Turner Syndrome Recruiting

2024-518557-42-00 Phase IV 1 country Region Midtjylland
Maternal Mental Health (MAMA) Study. Short time treatment with female sex hormone to prevent postpartum depression in a high-risk group Ended

2024-518028-63-00 Phase II 1 country Rigshospitalet
Stopstudy Ended

2023-505143-39-00 Phase IV 1 country Amsterdam UMC
Estrogen replacement therapy (ERT) for treatment of adolescent anorexia nervosa – An open label study Ended

2024-519908-27-01 Phase II 1 country Universitetssykehuset Nord-Norge HF

Showing 1–12 of 12 trials

← All drugs A–Z